Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03396926
Brief Title: Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery

First Submitted : January 5, 2018
First Submitted that Met QC Criteria : January 5, 2018
First Posted : January 11, 2018

Last Update Submitted that Met QC Criteria : April 29, 2019
Last Update Posted : May 1, 2019